Patents by Inventor Nancy KLIMAS

Nancy KLIMAS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating Parkinson's Disease with intranasal delivery of insulin and glutathione
    Patent number: 11883466
    Abstract: A method for treating Parkinson's disease where insulin and GSH may be administered intranasally. The GSH and insulin that is administered may be in varying doses at least once daily. The GSH and insulin may be administered sequentially and/or simultaneously and the medications may be administered for differing periods of time depending upon a patient's tolerance and response to the GSH and insulin. The GSH and the insulin may be administered for a certain period of time and/or indefinitely.
    Type: Grant
    Filed: June 23, 2022
    Date of Patent: January 30, 2024
    Assignee: Gateway Institute for Brain Research, LLC
    Inventor: Nancy Klimas
  • Method of treating Parkinson's disease with intranasal delivery of insulin and glutathione
    Patent number: 11883465
    Abstract: A method for treating Parkinson's disease where insulin and GSH may be administered intranasally. The GSH and insulin that is administered may be in varying doses at least once daily. The GSH and insulin may be administered sequentially and/or simultaneously and the medications may be administered for differing periods of time depending upon a patient's tolerance and response to the GSH and insulin. The GSH and the insulin may be administered for a certain period of time and/or indefinitely.
    Type: Grant
    Filed: June 23, 2022
    Date of Patent: January 30, 2024
    Assignee: Gateway Institute for Brain Research, LLC
    Inventor: Nancy Klimas
  • Method of treating Parkinson's disease with intranasal delivery of insulin and glutathione
    Patent number: 11813313
    Abstract: A method for treating Parkinson's disease where insulin and GSH may be administered intranasally. The GSH and insulin that is administered may be in varying doses at least once daily. The GSH and insulin may be administered sequentially and/or simultaneously and the medications may be administered for differing periods of time depending upon a patient's tolerance and response to the GSH and insulin. The GSH and the insulin may be administered for a certain period of time and/or indefinitely.
    Type: Grant
    Filed: January 26, 2022
    Date of Patent: November 14, 2023
    Assignee: Gateway Institute for Brain Research, LLC
    Inventor: Nancy Klimas
  • METHOD OF TREATING PARKINSON'S DISEASE WITH INTRANASAL DELIVERY OF INSULIN AND GLUTATHIONE
    Publication number: 20220313788
    Abstract: A method for treating Parkinson's disease where insulin and GSH may be administered intranasally. The GSH and insulin that is administered may be in varying doses at least once daily. The GSH and insulin may be administered sequentially and/or simultaneously and the medications may be administered for differing periods of time depending upon a patient's tolerance and response to the GSH and insulin. The GSH and the insulin may be administered for a certain period of time and/or indefinitely.
    Type: Application
    Filed: June 23, 2022
    Publication date: October 6, 2022
    Inventor: Nancy Klimas
  • METHOD OF TREATING PARKINSON'S DISEASE WITH INTRANASAL DELIVERY OF INSULIN AND GLUTATHIONE
    Publication number: 20220313787
    Abstract: A method for treating Parkinson's disease where insulin and GSH may be administered intranasally. The GSH and insulin that is administered may be in varying doses at least once daily. The GSH and insulin may be administered sequentially and/or simultaneously and the medications may be administered for differing periods of time depending upon a patient's tolerance and response to the GSH and insulin. The GSH and the insulin may be administered for a certain period of time and/or indefinitely.
    Type: Application
    Filed: June 23, 2022
    Publication date: October 6, 2022
    Inventor: Nancy Klimas
  • METHOD OF TREATING PARKINSON'S DISEASE WITH INTRANASAL DELIVERY OF INSULIN AND GLUTATHIONE
    Publication number: 20220265778
    Abstract: A method for treating Parkinson's disease where insulin and GSH may be administered intranasally. The GSH and insulin that is administered may be in varying doses at least once daily. The GSH and insulin may be administered sequentially and/or simultaneously and the medications may be administered for differing periods of time depending upon a patient's tolerance and response to the GSH and insulin. The GSH and the insulin may be administered for a certain period of time and/or indefinitely.
    Type: Application
    Filed: January 26, 2022
    Publication date: August 25, 2022
    Inventor: Nancy Klimas
  • Analyzing immune signaling networks for identification of therapeutic targets in complex chronic medical disorders
    Patent number: 10777298
    Abstract: A general method of analyzing immune signaling networks for identification of potential therapeutic targets in complex, chronic medical disorders is described. The disclosure provides the CD3?/CD56+ natural killer (NK) cell population as a potential therapeutic target in the clinically-overlapping disorders Gulf War Illness (GWI) and Myalg Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). The disclosure also provides a method for improving or restoring Natural Killer (NK) cell function by stimulating the NK cells with interleukin-15 (IL-15).
    Type: Grant
    Filed: October 14, 2014
    Date of Patent: September 15, 2020
    Assignees: Nova Southeastern University, University of Miami, University of Alberta, TEC Edmonton
    Inventors: Mary Ann Fletcher, Gordon Broderick, Nancy Klimas, Zachary Barnes
  • Method for Compiling A Genomic Database for A Complex Disease And Method for Using The Compiled Database to Identify Genetic Patterns in The Complex Disease to Establish Diagnostic Biomarkers
    Publication number: 20200176086
    Abstract: The invention provides a method for compiling a genomic database for a complex disease, such as Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), and a method for using the database for identifying genetic patterns that can potentially categorize, diagnose, and/or predict therapeutics for the complex disease.
    Type: Application
    Filed: June 29, 2018
    Publication date: June 4, 2020
    Applicant: Nova Southeastern University
    Inventors: Nancy KLIMAS, Kelly HILTON, Kristina GEMAYEL
  • Analyzing Immune Signaling Networks for Identification of Therapeutic Targets in Complex Chronic Medical Disorders, Identification of a Natural Killer Cell Population as a Potential Therapeutic Target for Gulf War Illness And Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, And Modulation of Natural Killer Cell Function by Stimulation with Interleukin 15
    Publication number: 20160275236
    Abstract: A general method of analyzing immune signaling networks for identification of potential therapeutic targets in complex, chronic medical disorders is described. The disclosure provides the CD3?/CD56+ natural killer (NK) cell population as a potential therapeutic target in the clinically-overlapping disorders Gulf War Illness (GWI) and Myalg Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). The disclosure also provides a method for improving or restoring Natural Killer (NK) cell function by stimulating the NK cells with interleukin-15 (IL-15).
    Type: Application
    Filed: October 14, 2014
    Publication date: September 22, 2016
    Inventors: Mary Ann FLETCHER, Gordan BRODERICK, Nancy KLIMAS, Zachary BARNES